Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays.
about
Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screeningDesign, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.A role for the mu opioid receptor in the antidepressant effects of buprenorphine.The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.Role of µ, κ, and δ opioid receptors in tibial inhibition of bladder overactivity in cats.Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mOpioid system and Alzheimer's disease.Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.Approaches to Assess Functional Selectivity in GPCRs: Evaluating G Protein Signaling in an Endogenous Environment.Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.Brain opioid and nociceptin receptors are involved in regulation of bombesin-induced activation of central sympatho-adrenomedullary outflow in the rat.Binding characteristics of [3H]14-methoxymetopon, a high affinity mu-opioid receptor agonist.Comparative analysis of pharmacological properties of xanomeline and N-desmethylclozapine in rat brain membranes.
P2860
Q24804972-E9C74808-94F0-4786-BD1A-12C0775E213CQ33893723-B7B072E9-AA34-4E3C-9AA9-AB2052D665B2Q34544184-39404BBD-5CF0-40EF-82BB-C9E78C5FB10BQ34553463-103EC1B9-2189-411D-AFA6-6062ADB7A7DBQ35044112-D0F843B0-189B-4AD1-B17E-EE985A072E13Q36015414-035030D3-4D2A-437E-8DF3-695AC1EBA610Q36186158-24AECC08-7EF6-4C8B-8A56-5A87E6CFF28BQ37317909-1C8324A0-681B-4E65-B225-6F4E17CEA10DQ38004941-7402C067-002E-4F4B-A036-B15DBE58FFA3Q38373652-C66FBE6A-BD68-450F-B315-69F77203D004Q38442583-C11F2A36-223F-4EC4-BA8B-4674B5FF5222Q43117967-B1D6FA03-F82C-4840-A5DB-AD3822F4938EQ44332515-07CEEE62-A797-499D-BCAD-2AB60DD05D0CQ44342374-FD0CFF88-FD35-4BB8-B82D-8C4DDCA51D4EQ48600420-F879F5F2-F26B-4FBC-91E3-4E0F5EB9F072
P2860
Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mu-opioid receptor specific an ...... [35S]GTPgammaS binding assays.
@ast
Mu-opioid receptor specific an ...... [35S]GTPgammaS binding assays.
@en
type
label
Mu-opioid receptor specific an ...... [35S]GTPgammaS binding assays.
@ast
Mu-opioid receptor specific an ...... [35S]GTPgammaS binding assays.
@en
prefLabel
Mu-opioid receptor specific an ...... [35S]GTPgammaS binding assays.
@ast
Mu-opioid receptor specific an ...... [35S]GTPgammaS binding assays.
@en
P2093
P1476
Mu-opioid receptor specific an ...... [35S]GTPgammaS binding assays
@en
P2093
Krassnig R
Maldonado R
Traynor JR
P304
P356
10.1016/S0014-2999(99)00610-X
P407
P577
1999-10-01T00:00:00Z